Publications found:
512,290
Sort by:
Retail Pharmacy De-identified Health Data Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dataset Type [DSCSA Data {By Buyer Type (Pharmaceutical Manufacturers, Drug Distributors, Regulatory Tech Vendors, Healthcare SaaS Vendors, Others)}; Market Basket Data {By Buyer Type (CPG & Pharma Brands, Marketing & AdTech Firms, Health Insurers & PBMs, Retail Analytics Platforms, Others)}; Prior Authorization Data {By Buyer Type (Payers & PBMs, Pharma Market Access Teams, Health IT Providers, Consulting & Policy Firms, Others)}; Inventory Data {By Buyer Type (Pharma Manufacturers, Distributors/Wholesalers, AI/ML Inventory Optimization Vendors, Others)}; Episodic Data/Pharmacy Rx Claims Data {By Buyer Type (Value-based Payers & ACOs, Pharma Outcomes Teams, Real-world Evidence Vendors, CMS & Government Organizations, Others)}], By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Retail Pharmacy De-identified Health Data Market was valued at USD 8.11 Billion in 2024 and is expected to reach USD 13.69 Billion by 2030 with a CAGR of 9.09%. The Global...
August 2025
186 pages
Self-monitoring Blood Glucose Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Hospitals, Home Settings, and Diagnostic Centers), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Self-monitoring Blood Glucose Market has valued at USD 10.28 Billion in 2024 and is expected to reach USD 16.87 billion by 2030 with a CAGR of 8.61% during the forecast period....
August 2025
188 pages
SGLT2 Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (Jardiance, Farmiga, Inpefa, Invokana, Others), By Indication (Type 2 Diabetes, Cardiovascular, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global SGLT2 Inhibitors Market was valued at USD 15.37 Billion in 2024 and is expected to reach USD 21.44 Billion by 2030 with a CAGR of 5.90%. These oral antidiabetic agents have eme...
August 2025
185 pages